• Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Lowered to $2.20 at UBS Group

    Source: Buzz FX / 28 Jan 2025 09:06:18   America/Chicago


    Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Lowered to $2.20 at UBS Group Written by MarketBeat January 28, 2025 Share Link copied to clipboard. Zentalis Pharmaceuticals ( NASDAQ:ZNTL - Get Free Report ) had its target price reduced
    Read more...
Share on,